Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR

American Journal of Hypertension

Volumn 13, Issue 10, 2000, Pages 1117-1124

  Kubo, Atsushi ^a   Fukuda, Noboru ^a   Teng, Jian ^a   Satoh, Chikara ^a   Nakayama, Mari ^a   Kishioka, Hirobumi ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Angiotensin II; CDK; Cell cycle; P27(kip1); Receptor; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMAL; BENZIMIDAZOLES; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DNA; FLOW CYTOMETRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TETRAZOLES;

EID: 0033808963     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)00298-3     Document Type: Article

References (42)

1. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats
2. Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension
3. Calcium signaling
4. Calcium signaling in neurons: Molecular mechanisms and cellular consequences
5. Angiotensin II can regulate gene expression by the AP-1 binding sequence via protein kinase C dependent pathway
6. Angiotensin and cell growth: A link to cardiovascular hypertrophy?
7. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
8. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats
9. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats
10. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β
11. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β
12. Regulation of bFGF expression and ANG II secretion in cardiac myocytes and microvascular endothelial cells
13. Effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats
14. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats
15. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats
16. Participation of proteolysis and transforming growth factor βl activation in growth of cultured smooth muscle cells from spontaneously hypertensive rats
17. Antisense oligodeoxynucleotide complementary to PDGF A-chain mRNA inhibits the arterial proliferation in spontaneously hypertensive rats without alteration of blood pressure
18. Bunazosin hydrochloride inhibits exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats by suppressing the response to growth factors
19. Role of endogenous angiotensin II in the expression of growth factors and the cell cycle in vascular smooth muscle cells from SHR
20. Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats
21. Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into S phase of the cell cycle
22. Mammmalian Gi cyclin
23. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
24. The smooth muscle cell - II. Growth of smooth muscle in culture and formation of elastic fibers
25. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle
26. Coupled reverse transcription-polymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping
27. Quantitation of mRNA by the kinetic polymerase chain reaction assay: A tool for monitoring P-glycoprotein expression
28. Dual control of cell growth by somatomedins and platelet-derived growth factor
29. Early signals in the mitogenic response
30. Phosphorylation of the retinoblastoma protein by cdk2
31. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
32. Association of human cyclin E with a periodic G1-S phase protein kinase
33. Differential regulation of p27(k1p 1) levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells
34. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats
35. Transforming growth factor β regulation of cell proliferation
36. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell culture
37. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture
38. Characteristics and expression of transforming growth factor-β receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats
39. Abnormal regulation of TGF-β receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II
40. Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1
41. Cell cycle. Stifled by inhibitors
42. Insensitivity to growth inhibition of TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells